Blue Sail Medical Co.,Ltd. (SHE:002382)
China
· Delayed Price · Currency is CNY 5.49
-0.15 (-2.66%)
Jun 13, 2025, 2:45 PM CST
Blue Sail Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 6,200 | 6,177 | 4,850 | 4,834 | 8,064 | 7,824 | Upgrade
|
Other Revenue | 76.37 | 76.37 | 76.73 | 66.18 | 44.59 | 45.49 | Upgrade
|
| Revenue | 6,276 | 6,253 | 4,927 | 4,900 | 8,109 | 7,869 | Upgrade
|
Revenue Growth (YoY) | 18.69% | 26.91% | 0.54% | -39.56% | 3.04% | 126.42% | Upgrade
|
Cost of Revenue | 5,245 | 5,262 | 4,393 | 4,481 | 4,382 | 2,814 | Upgrade
|
Gross Profit | 1,031 | 991.03 | 533.82 | 419.17 | 3,726 | 5,056 | Upgrade
|
Selling, General & Admin | 808.9 | 814.49 | 788.43 | 701.86 | 765.15 | 681.17 | Upgrade
|
Research & Development | 326.88 | 341.92 | 290.75 | 352.49 | 438.52 | 291.44 | Upgrade
|
Other Operating Expenses | 47.59 | 33.18 | 27.56 | 36.92 | 54.78 | 34.39 | Upgrade
|
Operating Expenses | 1,197 | 1,212 | 1,125 | 1,093 | 1,279 | 1,053 | Upgrade
|
Operating Income | -165.18 | -221.29 | -591.62 | -674.02 | 2,448 | 4,003 | Upgrade
|
Interest Expense | -293.41 | -278.98 | -180.47 | -129.48 | -133.32 | -189.92 | Upgrade
|
Interest & Investment Income | 33.07 | 30.38 | 40.67 | 294.44 | 81.06 | 100.11 | Upgrade
|
Currency Exchange Gain (Loss) | 53.09 | 53.09 | 33.88 | 62.8 | -86.36 | -149.76 | Upgrade
|
Other Non Operating Income (Expenses) | 10.95 | -5.72 | -6.69 | -12.26 | -27.4 | -4.25 | Upgrade
|
EBT Excluding Unusual Items | -361.48 | -422.51 | -704.23 | -458.51 | 2,282 | 3,759 | Upgrade
|
Impairment of Goodwill | - | - | - | - | -1,698 | -1,755 | Upgrade
|
Gain (Loss) on Sale of Investments | 121.13 | -11.1 | 70.63 | -6.74 | 1,098 | 1.06 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.75 | -0.84 | -1.92 | 0.07 | -1.89 | 3.95 | Upgrade
|
Asset Writedown | -38.48 | -6.29 | -21.47 | -6.94 | -370.68 | -19.87 | Upgrade
|
Other Unusual Items | 52.56 | 39.14 | 34.38 | 66.26 | 38.08 | 29.04 | Upgrade
|
Pretax Income | -227.03 | -401.6 | -622.61 | -405.86 | 1,347 | 2,018 | Upgrade
|
Income Tax Expense | 56.62 | 63.32 | -54.25 | -33.54 | 191.65 | 255.34 | Upgrade
|
Earnings From Continuing Operations | -283.65 | -464.92 | -568.36 | -372.32 | 1,156 | 1,763 | Upgrade
|
Minority Interest in Earnings | 13.98 | 19.31 | - | 0 | 0 | -4.57 | Upgrade
|
Net Income | -269.67 | -445.61 | -568.36 | -372.32 | 1,156 | 1,758 | Upgrade
|
Net Income to Common | -269.67 | -445.61 | -568.36 | -372.32 | 1,156 | 1,758 | Upgrade
|
Net Income Growth | - | - | - | - | -34.28% | 258.66% | Upgrade
|
Shares Outstanding (Basic) | 1,006 | 1,013 | 1,015 | 1,006 | 1,023 | 966 | Upgrade
|
Shares Outstanding (Diluted) | 1,006 | 1,013 | 1,015 | 1,006 | 1,051 | 1,016 | Upgrade
|
Shares Change (YoY) | -1.42% | -0.21% | 0.86% | -4.22% | 3.36% | 5.73% | Upgrade
|
EPS (Basic) | -0.27 | -0.44 | -0.56 | -0.37 | 1.13 | 1.82 | Upgrade
|
EPS (Diluted) | -0.27 | -0.44 | -0.56 | -0.37 | 1.10 | 1.73 | Upgrade
|
EPS Growth | - | - | - | - | -36.42% | 239.22% | Upgrade
|
Free Cash Flow | -378.84 | -638.43 | -847.03 | -402.39 | -336.22 | 2,468 | Upgrade
|
Free Cash Flow Per Share | -0.38 | -0.63 | -0.83 | -0.40 | -0.32 | 2.43 | Upgrade
|
Dividend Per Share | - | - | - | 0.400 | - | 0.400 | Upgrade
|
Dividend Growth | - | - | - | - | - | 300.00% | Upgrade
|
Gross Margin | 16.43% | 15.85% | 10.83% | 8.55% | 45.96% | 64.25% | Upgrade
|
Operating Margin | -2.63% | -3.54% | -12.01% | -13.75% | 30.19% | 50.87% | Upgrade
|
Profit Margin | -4.30% | -7.13% | -11.54% | -7.60% | 14.25% | 22.35% | Upgrade
|
Free Cash Flow Margin | -6.04% | -10.21% | -17.19% | -8.21% | -4.15% | 31.37% | Upgrade
|
EBITDA | 346.58 | 289.58 | -84.34 | -200.95 | 2,765 | 4,217 | Upgrade
|
EBITDA Margin | 5.52% | 4.63% | -1.71% | -4.10% | 34.10% | 53.58% | Upgrade
|
D&A For EBITDA | 511.77 | 510.87 | 507.27 | 473.06 | 317.51 | 213.71 | Upgrade
|
EBIT | -165.18 | -221.29 | -591.62 | -674.02 | 2,448 | 4,003 | Upgrade
|
EBIT Margin | -2.63% | -3.54% | -12.01% | -13.75% | 30.19% | 50.87% | Upgrade
|
Effective Tax Rate | - | - | - | - | 14.22% | 12.65% | Upgrade
|
Revenue as Reported | 6,276 | 6,253 | 4,927 | 4,900 | 8,109 | 7,869 | Upgrade
|
Advertising Expenses | - | 80.29 | 88.32 | 54.61 | 24.98 | 115.52 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.